Copy number variations inDCC/18q andERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer-Reference-Cited by-同舟云学术

Copy number variations inDCC/18q andERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer

Published:2017-02-20 Issue:7 Volume:140 Page:1653-1661
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Sefrioui David¹²³,Vermeulin Thomas⁴,Blanchard France³⁵,Chapusot Caroline⁶,Beaussire Ludivine²,Armengol-Debeir Laura¹,Sesboué Richard²³,Gangloff Alice¹²³,Hebbar Mohamed⁷,Copin Marie-Christine⁸,Houivet Estelle⁴,Schwarz Lilian⁹,Clatot Florian¹⁰,Tuech Jean-Jacques⁹,Bénichou Jacques⁴,Martin Laurent⁶,Bouvier Anne-Marie¹¹,Sabourin Jean-Christophe²³⁵,Sarafan-Vasseur Nasrin²³,Frébourg Thierry²,Lepage Côme¹¹,Michel Pierre¹²³,Di Fiore Frédéric¹²³¹⁰

Affiliation:

1. Digestive Oncology Unit, Department of Hepato-Gastroenterology; Rouen University Hospital; Rouen France

2. Inserm U1079, University of Rouen, Institute for Biomedical Research and Innovation; Rouen France

3. EquIpe de Recherche en ONcogie (IRON), Rouen University Hospital; Rouen France

4. Department of Biostatistics; Rouen University Hospital; Rouen France

5. Department of Pathology; Rouen University Hospital; Rouen France

6. Department of Pathology; Dijon University Hospital, University of Burgundy; Dijon France

7. Department of Medical Oncology; Lille University Hospital; Lille France

8. Department of Pathology; Lille University Hospital; Lille France

9. Department of Surgery; Rouen University Hospital; Rouen France

10. Department of Medical Oncology; Centre Henri Becquerel; Rouen France

11. Digestive Cancer Registry of Burgundy, INSERM U866, University Hospital Dijon, University of Burgundy; Dijon France

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference48 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004

3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;André;J Clin Oncol,2009

4. Prognostic effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab: a post hoc analysis of the PETACC-8 trial;Taieb;JAMA Oncol,2016

5. ERCC1, XRCC1 and GSTP1 Single nucleotide polymorphisms and survival of patients with colon cancer receiving oxaliplatin-based adjuvant chemotherapy;Zaanan;J Cancer,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SNP array genomic analysis of matched pairs of brain and liver metastases in primary colorectal cancer;Journal of Cancer Research and Clinical Oncology;2023-11-27

2. Chromosome 18;Cancer Genes: Volume 2;2023-08-16

3. Characterizing HDAC Pathway Copy Number Variation in Pan-Cancer;Pathology and Oncology Research;2022-06-13

4. Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology;Journal of Clinical Laboratory Analysis;2022-02-17

5. Genomic profiling of sporadic liver metastatic colorectal cancer;Seminars in Cancer Biology;2021-06